Covid-19 vaccine maker offers shares in China’s second costliest IPO

The offer price for CanSino’s secondary listing made it the second-most expensive initial public offering in China, as the nation’s tentative signs of economic growth fulled optimism and sparked off a 9-per cent rally this year in Asia’s largest capital market.



Post a Comment

0 Comments